These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16424054)
1. Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity. Park JE; Facciponte J; Chen X; MacDonald I; Repasky EA; Manjili MH; Wang XY; Subjeck JR Cancer Res; 2006 Jan; 66(2):1161-8. PubMed ID: 16424054 [TBL] [Abstract][Full Text] [Related]
2. The chaperoning properties of mouse grp170, a member of the third family of hsp70 related proteins. Park J; Easton DP; Chen X; MacDonald IJ; Wang XY; Subjeck JR Biochemistry; 2003 Dec; 42(50):14893-902. PubMed ID: 14674765 [TBL] [Abstract][Full Text] [Related]
3. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Wang XY; Chen X; Manjili MH; Repasky E; Henderson R; Subjeck JR Cancer Res; 2003 May; 63(10):2553-60. PubMed ID: 12750279 [TBL] [Abstract][Full Text] [Related]
4. Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I. Facciponte JG; Wang XY; Subjeck JR Eur J Immunol; 2007 Aug; 37(8):2268-79. PubMed ID: 17615582 [TBL] [Abstract][Full Text] [Related]
5. Distinct binding sites for the ATPase and substrate-binding domain of human Hsp70 on the cell surface of antigen presenting cells. Zitzler S; Hellwig A; Hartl FU; Wieland F; Diestelkötter-Bachert P Mol Immunol; 2008 Sep; 45(15):3974-83. PubMed ID: 18657319 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with a chaperone complex based on PSCA and GRP170 adjuvant enhances the CTL response and inhibits the tumor growth in mice. Huo W; Ye J; Liu R; Chen J; Li Q Vaccine; 2010 Aug; 28(38):6333-7. PubMed ID: 20637304 [TBL] [Abstract][Full Text] [Related]
7. Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity. Calderwood SK; Theriault JR; Gong J Eur J Immunol; 2005 Sep; 35(9):2518-27. PubMed ID: 16144035 [TBL] [Abstract][Full Text] [Related]
8. Scavenger receptor-A negatively regulates antitumor immunity. Wang XY; Facciponte J; Chen X; Subjeck JR; Repasky EA Cancer Res; 2007 May; 67(10):4996-5002. PubMed ID: 17510431 [TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory functions of membrane-bound and exported heat shock protein 70. Radons J; Multhoff G Exerc Immunol Rev; 2005; 11():17-33. PubMed ID: 16385841 [TBL] [Abstract][Full Text] [Related]
10. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen. Wang XY; Sun X; Chen X; Facciponte J; Repasky EA; Kane J; Subjeck JR J Immunol; 2010 Jun; 184(11):6309-19. PubMed ID: 20439916 [TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum chaperone glucose regulated protein 170-Pokemon complexes elicit a robust antitumor immune response in vivo. Yuan B; Xian R; Wu X; Jing J; Chen K; Liu G; Zhou Z Immunobiology; 2012 Jul; 217(7):738-42. PubMed ID: 22317751 [TBL] [Abstract][Full Text] [Related]
12. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice. Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048 [TBL] [Abstract][Full Text] [Related]
13. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy. Li Y; Subjeck J; Yang G; Repasky E; Wang XY Vaccine; 2006 Jun; 24(25):5360-70. PubMed ID: 16714072 [TBL] [Abstract][Full Text] [Related]
14. Heat shock protein derivatives for delivery of antigens to antigen presenting cells. Nishikawa M; Takemoto S; Takakura Y Int J Pharm; 2008 Apr; 354(1-2):23-7. PubMed ID: 17980980 [TBL] [Abstract][Full Text] [Related]
15. The hsp110 and Grp1 70 stress proteins: newly recognized relatives of the Hsp70s. Easton DP; Kaneko Y; Subjeck JR Cell Stress Chaperones; 2000 Oct; 5(4):276-90. PubMed ID: 11048651 [TBL] [Abstract][Full Text] [Related]
16. Fusion protein of ATPase domain of Hsc70 with TRP2 acting as a tumor vaccine against B16 melanoma. Zhang H; Wang W; Li Q; Huang W Immunol Lett; 2006 Jun; 105(2):167-73. PubMed ID: 16580737 [TBL] [Abstract][Full Text] [Related]
17. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation. Murshid A; Gong J; Calderwood SK Expert Rev Vaccines; 2008 Sep; 7(7):1019-30. PubMed ID: 18767951 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a receptor for heat shock protein 70 on macrophages and monocytes. Sondermann H; Becker T; Mayhew M; Wieland F; Hartl FU Biol Chem; 2000 Dec; 381(12):1165-74. PubMed ID: 11209751 [TBL] [Abstract][Full Text] [Related]
19. Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells. Thériault JR; Mambula SS; Sawamura T; Stevenson MA; Calderwood SK FEBS Lett; 2005 Mar; 579(9):1951-60. PubMed ID: 15792802 [TBL] [Abstract][Full Text] [Related]
20. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis. Liu B; Ye D; Song X; Zhao X; Yi L; Song J; Zhang Z; Zhao Q Vaccine; 2008 Mar; 26(10):1387-96. PubMed ID: 18272260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]